Skip to main content

Table 1 Clinicopathological factors in 30 patients with liver metastases from Nasopharyngeal Carcinoma

From: Partial hepatectomy for liver metastases from nasopharyngeal carcinoma: a comparative study and review of the literature

 

Resection group

Control group

P value

 

(n = 15)

(n = 15)

 

Age (y)

46 (36–63)

43 (26–63)

>0.999

Gender

  

>0.999

 Male

12 (80%)

12 (80%)

 

 Female

3 (20%)

3 (20%)

 

Presentation

  

>0.999

 Synchronous

0 (0%)

1 (6.7%)

 

 Metachronous

15 (100%)

14 (93.3%)

 

Abdominal symptom

  

0.598

 Positive

1 (6.7%)

3 (20%)

 

 Negative

14 (93.3%)

12 (80%)

 

Interval from NPC to hepatic metastasis

  

0.427

 <12 (mo)

3 (20%)

6 (40%)

 

 ≥12 (mo)

12 (80%)

9 (60%)

 

PFS (mo)

  

>0.999

 <12 (mo)

7 (46.7%)

8 (53.3%)

 

 ≥12 (mo)

8 (53.3%)

7 (46.7%)

 

EBERs

  

>0.999

 Positive

15 (100%)

15 (100%)

 

 Negative

0 (0%)

0 (0%)

 

Child-Pugh Grading

  

>0.999

 Grade A

15 (100%)

15 (100%)

 

 Grade B

0 (0%)

0 (0%)

 

Hepatitis virus B infection

  

>0.999

 Positive

2 (13.3%)

1 (6.7%)

 

 Negative

13 (86.7%)

14 (93.3%)

 
  1. Continuous data were expressed as median (range).
  2. Categorical variables were reported with (%).
  3. PFS: progression-free survival from diagnosis of NPC to discovery of liver metastasis.3.
  4. EBERs: Epstein-Barr -Virus encoded small RNAs.